{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:38:52Z","timestamp":1794958732327,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI069923"],"award-info":[{"award-number":["U01AI069923"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Late antiretroviral treatment initiation for HIV disease worsens health outcomes and contributes to ongoing transmission. We investigated whether socioeconomic inequalities exist in access to treatment in a setting with universal access to care and treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study investigated the association of educational level, used as a proxy for socioeconomic status, with late treatment initiation and treatment initiation with advanced disease. Study participants included adults (\u226525\u2009years) who started treatment from 2005 to 2018 at Instituto Nacional de Infectologia Evandro Chagas of Funda\u00e7\u00e3o Oswaldo Cruz (INI\/FIOCRUZ), Rio de Janeiro, Brazil. Educational level was categorized following UNESCO\u2019s International Standard Classification of Education: incomplete basic education, basic education, secondary level, and tertiary level. We defined late treatment initiation as those initiating treatment with a CD4\u2009&lt;\u2009350 cells\/mL or an AIDS-defining event, and treatment initiation with advanced disease as those initiating treatment with a CD4\u2009&lt;\u2009200 cells\/mL or an AIDS-defining event. A directed acyclic graph (DAG) was constructed to represent the theoretical-operational model and to understand the involvement of covariates. Logistic regression models were used to estimate the adjusted odds ratios (aOR) and 95% confidence intervals (95%CI). Multiple imputation using a chained equations approach was used to treat missing values and non-linear terms for continuous variables were tested.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 3226 individuals composed the study population: 876 (27.4%) had incomplete basic education, 540 (16.9%) basic, 1251 (39.2%) secondary level, and 525 (16.4%) tertiary level. Late treatment initiation was observed for 2076 (64.4%) while treatment initiation with advanced disease was observed for 1423 (44.1%). Compared to tertiary level of education, incomplete basic, basic and secondary level increased the odds of late treatment initiation by 89% (aOR:1.89 95%CI:1.47\u20132.43), 61% (aOR:1.61 95%CI:1.23\u20132.10), and 35% (aOR:1.35 95%CI:1.09\u20131.67). Likewise, the odds of treatment initiation with advanced disease was 2.5-fold (aOR:2.53 95%CI:1.97\u20133.26), 2-fold (aOR:2.07 95%CI:1.59\u20132.71), 1.5-fold (aOR:1.51 95%CI:1.21\u20131.88) higher for those with incomplete basic, basic and secondary level education compared to tertiary level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite universal access to HIV care and antiretroviral treatment, late treatment initiation and social inequalities persist. Lower educational level significantly increased the odds of both outcomes, reinforcing the existence of barriers to \u201cuniversal\u201d antiretroviral treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-10421-8","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T20:13:38Z","timestamp":1613852018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Late initiation of antiretroviral therapy: inequalities by educational level despite universal access to care and treatment"],"prefix":"10.1186","volume":"21","author":[{"given":"Amanda","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio J.","family":"Struchiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara E.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdilea G.","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9746-719X","authenticated-orcid":false,"given":"Paula M.","family":"Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"key":"10421_CR1","doi-asserted-by":"crossref","unstructured":"Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61-4.","DOI":"10.1111\/j.1468-1293.2010.00857.x"},{"issue":"9","key":"10421_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001510","volume":"10","author":"A Mocroft","year":"2013","unstructured":"Mocroft A, Lundgren JD, Sabin ML, Monforte A, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the collaboration of observational HIV epidemiological research Europe study (COHERE). PLoS Med. 2013;10(9):e1001510.","journal-title":"PLoS Med"},{"key":"10421_CR3","doi-asserted-by":"crossref","unstructured":"MS. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Manejo da Infec\u00e7\u00e3o pelo HIV em Adultos. 2018. Available at http:\/\/www.aids.gov.br\/pt-br\/profissionais-de-saude\/hiv\/protocolos-clinicos-e-manuais. Accessed 12 Dec 2019.","DOI":"10.5205\/1981-8963-v12i12a238453p3533-3534-2018"},{"key":"10421_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2334-12-99","volume":"12","author":"A Grangeiro","year":"2012","unstructured":"Grangeiro A, Escuder MM, Pereira JC. Late entry into HIV care: lessons from Brazil, 2003 to 2006. BMC Infect Dis. 2012;12:99.","journal-title":"BMC Infect Dis"},{"key":"10421_CR5","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1186\/1471-2458-14-1313","volume":"14","author":"S MacCarthy","year":"2014","unstructured":"MacCarthy S, Brignol S, Reddy M, Nunn A, Dourado I. Making the invisible, visible: a cross-sectional study of late presentation to HIV\/AIDS services among men who have sex with men from a large urban center of Brazil. BMC Public Health. 2014;14:1313.","journal-title":"BMC Public Health"},{"key":"10421_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1590\/S1518-8787.2016050006352","volume":"50","author":"S MacCarthy","year":"2016","unstructured":"MacCarthy S, Brignol S, Reddy M, Nunn A, Dourado I. Late presentation to HIV\/AIDS care in Brazil among men who self-identify as heterosexual. Rev Saude Publica. 2016;50:54.","journal-title":"Rev Saude Publica"},{"key":"10421_CR7","doi-asserted-by":"publisher","first-page":"5165313","DOI":"10.1155\/2019\/5165313","volume":"2019","author":"PRG Pacheco","year":"2019","unstructured":"Pacheco PRG, Zara A, Silva ESLC, Turchi MD. Late onset of antiretroviral therapy in adults living with HIV in an urban area in Brazil: prevalence and risk factors. J Trop Med. 2019;2019:5165313.","journal-title":"J Trop Med"},{"issue":"5","key":"10421_CR8","first-page":"587","volume":"72","author":"P Sobrino-Vegas","year":"2016","unstructured":"Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, et al. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013. J Inf Secur. 2016;72(5):587\u201396.","journal-title":"J Inf Secur"},{"key":"10421_CR9","doi-asserted-by":"crossref","unstructured":"The late presenters working group in COHERE in EuroCoord. Late presentation for HIV care across Europe: update from the collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015;20(47):1-12.","DOI":"10.2807\/1560-7917.ES.2015.20.47.30070"},{"issue":"7","key":"10421_CR10","first-page":"1128","volume":"60","author":"N Ford","year":"2015","unstructured":"Ford N, Mills EJ, Egger M. Editorial commentary: immunodeficiency at start of antiretroviral therapy: the persistent problem of late presentation to care. Clin Infect Dis. 2015;60(7):1128\u201330.","journal-title":"Clin Infect Dis"},{"key":"10421_CR11","doi-asserted-by":"publisher","first-page":"20024","DOI":"10.7448\/IAS.18.1.20024","volume":"18","author":"A Cescon","year":"2015","unstructured":"Cescon A, Patterson S, Davey C, Ding E, Raboud JM, Chan K, et al. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care. J Int AIDS Soc. 2015;18:20024.","journal-title":"J Int AIDS Soc"},{"issue":"18","key":"10421_CR12","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1056\/NEJMoa0807252","volume":"360","author":"MM Kitahata","year":"2009","unstructured":"Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815\u201326.","journal-title":"N Engl J Med"},{"issue":"11","key":"10421_CR13","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1016\/S2352-3018(15)00183-6","volume":"2","author":"C Cesar","year":"2015","unstructured":"Cesar C, Jenkins CA, Shepherd BE, Padgett D, Mejia F, Ribeiro SR, et al. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study. Lancet HIV. 2015;2(11):e492\u2013500.","journal-title":"Lancet HIV"},{"issue":"2","key":"10421_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/jac\/dkr478","volume":"67","author":"JA Perez-Molina","year":"2012","unstructured":"Perez-Molina JA, Diaz-Menendez M, Plana MN, Zamora J, Lopez-Velez R, Moreno S. Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials. J Antimicrob Chemother. 2012;67(2):312\u201321.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10421_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"key":"10421_CR16","unstructured":"WHO. The 2013 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2013. Available at https:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/en\/. Accessed 12 Dec 2019."},{"issue":"2","key":"10421_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2016.5148","volume":"316","author":"AJ Rodger","year":"2016","unstructured":"Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, et al. Sexual activity without condoms and risk of HIV transmission in Serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316(2):171\u201381.","journal-title":"JAMA."},{"issue":"4","key":"10421_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1037\/a0032694","volume":"68","author":"JA Pellowski","year":"2013","unstructured":"Pellowski JA, Kalichman SC, Matthews KA, Adler N. A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am Psychol. 2013;68(4):197\u2013209.","journal-title":"Am Psychol"},{"issue":"15","key":"10421_CR19","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1097\/QAD.0000000000000410","volume":"28","author":"S Lodi","year":"2014","unstructured":"Lodi S, Dray-Spira R, Touloumi G, Braun D, Teira R, D'Arminio Monforte A, et al. Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord. AIDS. 2014;28(15):2297\u2013306.","journal-title":"AIDS"},{"issue":"Suppl 4","key":"10421_CR20","doi-asserted-by":"publisher","first-page":"S517","DOI":"10.2105\/AJPH.2014.302200","volume":"104","author":"M Marmot","year":"2014","unstructured":"Marmot M, Allen JJ. Social determinants of health equity. Am J Public Health. 2014;104(Suppl 4):S517\u20139.","journal-title":"Am J Public Health"},{"issue":"2","key":"10421_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/09540121.2016.1211610","volume":"29","author":"DS Teixeira da Silva","year":"2017","unstructured":"Teixeira da Silva DS, Luz PM, Lake JE, Cardoso SW, Ribeiro S, Moreira RI, et al. Poor retention in early care increases risk of mortality in a Brazilian HIV-infected clinical cohort. AIDS Care. 2017;29(2):263\u20137.","journal-title":"AIDS Care"},{"issue":"1","key":"10421_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12879-016-1462-x","volume":"16","author":"LE Coelho","year":"2016","unstructured":"Coelho LE, Cardoso SW, Amancio RT, Moreira RI, Ribeiro SR, Coelho AB, et al. Predictors of opportunistic illnesses incidence in post combination antiretroviral therapy era in an urban cohort from Rio de Janeiro, Brazil. BMC Infect Dis. 2016;16(1):134.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10421_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059768","volume":"8","author":"B Grinsztejn","year":"2013","unstructured":"Grinsztejn B, Luz PM, Pacheco AG, Santos DV, Velasque L, Moreira RI, et al. Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS One. 2013;8(4):e59768.","journal-title":"PLoS One"},{"issue":"4","key":"10421_CR24","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1016\/S2352-3018(17)30015-2","volume":"4","author":"B Grinsztejn","year":"2017","unstructured":"Grinsztejn B, Jalil EM, Monteiro L, Velasque L, Moreira RI, Garcia AC, et al. Unveiling of HIV dynamics among transgender women: a respondent-driven sampling study in Rio de Janeiro, Brazil. Lancet HIV. 2017;4(4):e169\u2013e76.","journal-title":"Lancet HIV"},{"issue":"1","key":"10421_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/trgh.2018.0063","volume":"4","author":"ACG Ferreira","year":"2019","unstructured":"Ferreira ACG, Coelho LE, Jalil EM, Luz PM, Friedman RK, Guimaraes MRC, et al. Transcendendo: a cohort study of HIV-infected and uninfected transgender women in Rio de Janeiro, Brazil. Transgend Health. 2019;4(1):107\u201317.","journal-title":"Transgend Health"},{"key":"10421_CR26","first-page":"136","volume-title":"Causal inference in statistics : a primer","author":"J Pearl","year":"2016","unstructured":"Pearl J, Glymour M, Jewell NP. Causal inference in statistics : a primer. Chichester, West Sussex: Wiley; 2016. p. 136. xvii"},{"key":"10421_CR27","first-page":"758","volume-title":"Modern epidemiology. 3rd ed","author":"KJ Rothman","year":"2008","unstructured":"Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Wolters Kluwer Health\/Lippincott Williams & Wilkins; 2008. p. 758."},{"issue":"11","key":"10421_CR28","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1086\/652650","volume":"50","author":"KN Althoff","year":"2010","unstructured":"Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis. 2010;50(11):1512\u201320.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10421_CR29","doi-asserted-by":"publisher","first-page":"e490","DOI":"10.1016\/S2352-3018(16)30052-2","volume":"3","author":"L Coelho","year":"2016","unstructured":"Coelho L, Grinsztejn B, Castilho JL, De Boni R, Quintana MS, Campos DP, et al. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study. Lancet HIV. 2016;3(10):e490\u20138.","journal-title":"Lancet HIV."},{"issue":"6","key":"10421_CR30","first-page":"1887","volume":"45","author":"J Textor","year":"2016","unstructured":"Textor J, van der Zander B, Gilthorpe MS, Liskiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package 'dagitty'. Int J Epidemiol. 2016;45(6):1887\u201394.","journal-title":"Int J Epidemiol"},{"key":"10421_CR31","first-page":"615","volume-title":"Social epidemiology. Second edition. ed","author":"LF Berkman","year":"2014","unstructured":"Berkman LF, Kawachi I, Glymour MM. Social epidemiology. Second edition. ed. Oxford: Oxford University Press; 2014. p. 615. xvii"},{"issue":"1","key":"10421_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3851\/IMP1939","volume":"17","author":"P Sobrino-Vegas","year":"2012","unstructured":"Sobrino-Vegas P, Rodriguez-Urrego J, Berenguer J, Caro-Murillo AM, Blanco JR, Viciana P, et al. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care. Antivir Ther. 2012;17(1):1\u20138.","journal-title":"Antivir Ther"},{"issue":"4","key":"10421_CR33","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/00126334-200408010-00009","volume":"36","author":"E Girardi","year":"2004","unstructured":"Girardi E, Aloisi MS, Arici C, Pezzotti P, Serraino D, Balzano R, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr. 2004;36(4):951\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10421_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1086\/588673","volume":"198","author":"VD Lima","year":"2008","unstructured":"Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, Anema A, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis. 2008;198(1):59\u201367.","journal-title":"J Infect Dis"},{"issue":"1","key":"10421_CR35","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1097\/QAI.0b013e3182a39979","volume":"65","author":"D Avila","year":"2014","unstructured":"Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2014;65(1):e8\u201316.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10421_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1310\/hct1201-1","volume":"12","author":"JA Perez-Molina","year":"2011","unstructured":"Perez-Molina JA, Suarez-Lozano I, Del Arco A, Teira R, Bachiller P, Pedrol E, et al. Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant status. HIV Clin Trials. 2011;12(1):1\u20138.","journal-title":"HIV Clin Trials"},{"key":"10421_CR37","doi-asserted-by":"crossref","unstructured":"Mehraj V, Cox J, Lebouche B, Costiniuk C, Cao W, Li T, et al. Socio-economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015. J Int AIDS Soc. 2018;21(2)1\u201310.","DOI":"10.1002\/jia2.25034"},{"issue":"7","key":"10421_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25559","volume":"23","author":"SK Calabrese","year":"2020","unstructured":"Calabrese SK, Mayer KH. Stigma impedes HIV prevention by stifling patient-provider communication about U = U. J Int AIDS Soc. 2020;23(7):e25559.","journal-title":"J Int AIDS Soc"},{"issue":"Suppl 4","key":"10421_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/00333549101250S401","volume":"125","author":"HD Dean","year":"2010","unstructured":"Dean HD, Fenton KA. Addressing social determinants of health in the prevention and control of HIV\/AIDS, viral hepatitis, sexually transmitted infections, and tuberculosis. Public Health Rep. 2010;125(Suppl 4):1\u20135.","journal-title":"Public Health Rep"},{"issue":"5","key":"10421_CR40","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2105\/AJPH.2012.301069","volume":"103","author":"ML Hatzenbuehler","year":"2013","unstructured":"Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013;103(5):813\u201321.","journal-title":"Am J Public Health"},{"issue":"2","key":"10421_CR41","doi-asserted-by":"publisher","DOI":"10.2196\/13771","volume":"5","author":"TS Torres","year":"2019","unstructured":"Torres TS, Konda KA, Vega-Ramirez EH, Elorreaga OA, Diaz-Sosa D, Hoagland B, et al. Factors associated with willingness to use pre-exposure prophylaxis in Brazil, Mexico, and Peru: web-based survey among men who have sex with men. JMIR Public Health Surveill. 2019;5(2):e13771.","journal-title":"JMIR Public Health Surveill"},{"issue":"12","key":"10421_CR42","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1007\/s10461-018-2041-5","volume":"22","author":"M Reinius","year":"2018","unstructured":"Reinius M, Wiklander M, Wettergren L, Svedhem V, Eriksson LE. The relationship between stigma and health-related quality of life in people living with HIV who have full access to antiretroviral treatment: an assessment of Earnshaw and Chaudoir's HIV stigma framework using empirical data. AIDS Behav. 2018;22(12):3795\u2013806.","journal-title":"AIDS Behav"},{"issue":"10","key":"10421_CR43","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/QAD.0000000000000724","volume":"29","author":"JE Pachankis","year":"2015","unstructured":"Pachankis JE, Hatzenbuehler ML, Hickson F, Weatherburn P, Berg RC, Marcus U, et al. Hidden from health: structural stigma, sexual orientation concealment, and HIV across 38 countries in the European MSM internet survey. AIDS. 2015;29(10):1239\u201346.","journal-title":"AIDS."},{"issue":"3","key":"10421_CR44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5123\/S1679-49742015000300020","volume":"24","author":"FM Massignam","year":"2015","unstructured":"Massignam FM, Bastos JL, Nedel FB. Discrimination and health: a problem of access. Epidemiologia e Servi\u00e7os de Sa\u00fade. 2015;24(3):541\u20134.","journal-title":"Epidemiologia e Servi\u00e7os de Sa\u00fade"},{"key":"10421_CR45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1475-9276-11-80","volume":"11","author":"J Macinko","year":"2012","unstructured":"Macinko J, Mullachery P, Proietti FA, Lima-Costa MF. Who experiences discrimination in Brazil? Evidence from a large metropolitan region. Int J Equity Health. 2012;11:80.","journal-title":"Int J Equity Health"},{"key":"10421_CR46","doi-asserted-by":"crossref","unstructured":"Goncalves VF, Kerr LR, Mota RS, Macena RH, Almeida RL, Freire DG, et al. Incentives and barriers to HIV testing in men who have sex with men in a metropolitan area in Brazil. Cad Saude Publica. 2016;32(5)1\u201310.","DOI":"10.1590\/0102-311X00049015"},{"issue":"6","key":"10421_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1468-1293.2008.00566.x","volume":"9","author":"M Wolbers","year":"2008","unstructured":"Wolbers M, Bucher HC, Furrer H, Rickenbach M, Cavassini M, Weber R, et al. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV cohort study. HIV Med. 2008;9(6):397\u2013405.","journal-title":"HIV Med"},{"issue":"9","key":"10421_CR48","first-page":"1013","volume":"99","author":"VL Shavers","year":"2007","unstructured":"Shavers VL. Measurement of socioeconomic status in health disparities research. J Natl Med Assoc. 2007;99(9):1013\u201323.","journal-title":"J Natl Med Assoc"}],"updated-by":[{"DOI":"10.1186\/s12889-021-10683-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000}}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-10421-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-10421-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-10421-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T06:03:49Z","timestamp":1667023429000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-10421-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["10421"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-10421-8","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12889-021-10683-2","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"10 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12889-021-10683-2","URL":"https:\/\/doi.org\/10.1186\/s12889-021-10683-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Evandro Chagas Clinical Research Institute of the Oswaldo Cruz Foundation (INI\/FIOCRUZ, CAAE 0032.0.009.000\u201310) and was conducted according to the principles expressed in the Declaration of Helsinki. All patient records\/information were anonymized prior to analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"389"}}